Neurochemistry Changes Associated with Mutations in Familial Parkinson's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|35|4378-4391

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.35, 2010-12, pp. : 4378-4391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional Neurochemistry of Alzheimers Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 3, 2004-01 ,pp. : 265-293

Bentham Science Publishers

Access to resources Recommend Favorite

Rivastigmine effective in dementia associated with Parkinson's disease

By  

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Treatment Benefit and Daily Drug Costs Associated with Treating Parkinson’s Disease in a Parkinson’s Disease Clinic

By Müller T.  

CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. : 105-111

Adis International

Access to resources Recommend Favorite

Pramipexole and Levodopa in Early Parkinson's Disease: Dynamic Changes in Cost Effectiveness

By Noyes Katia   Dick Andrew W.   Holloway Robert G.   The Parkinson Study Group  

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1257-1270

Adis International

Access to resources Recommend Favorite

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson's Disease

By Jankovic Joseph  

CNS Drugs, Vol. 21, Iss. 8, 2007-01 ,pp. : 677-692

Adis International

Access to resources Recommend Favorite